Elevance Health Inc
ELV274.660USD
-8.420-2.97%
Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min
61.75BCap. mercado
10.44P/E TTM
Más Datos de Elevance Health Inc Compañía
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Información de la empresa
Símbolo de cotizaciónELV
Nombre de la empresaElevance Health Inc
Fecha de salida a bolsaOct 30, 2001
Fundada en2001
Director ejecutivoMs. Gail K. Boudreaux
Número de empleados103158
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 30
Dirección220 Virginia Avenue
CiudadINDIANAPOLIS
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46204
Teléfono18003311476
Sitio Webhttps://www.elevancehealth.com/
Símbolo de cotizaciónELV
Fecha de salida a bolsaOct 30, 2001
Fundada en2001
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Ryan M. Schneider
Mr. Ryan M. Schneider
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Ryan M. Schneider
Mr. Ryan M. Schneider
Independent Director
Independent Director
--
--
Desglose de ingresos
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
40.89B
0.00%
Product revenue
5.81B
0.00%
Service fees
2.07B
0.00%
Reconciliation
126.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
40.89B
0.00%
Product revenue
5.81B
0.00%
Service fees
2.07B
0.00%
Reconciliation
126.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Estadísticas de accionistas
Actualizado: vie., 1 de ago
Actualizado: vie., 1 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.17%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Global Advisors (US)
4.73%
T. Rowe Price Associates, Inc.
3.89%
Wellington Management Company, LLP
2.57%
Other
73.40%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.17%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Global Advisors (US)
4.73%
T. Rowe Price Associates, Inc.
3.89%
Wellington Management Company, LLP
2.57%
Other
73.40%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
51.30%
Investment Advisor/Hedge Fund
31.84%
Pension Fund
2.42%
Bank and Trust
2.40%
Research Firm
2.02%
Hedge Fund
1.78%
Sovereign Wealth Fund
1.45%
Family Office
0.27%
Family Office
0.27%
Other
6.26%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
3078
214.37M
95.19%
-5.02M
2025Q1
3135
209.98M
92.91%
-9.57M
2024Q4
3098
213.30M
93.78%
-5.08M
2024Q3
3004
212.78M
91.75%
-6.27M
2024Q2
2973
214.50M
92.28%
-4.31M
2024Q1
2940
212.64M
91.38%
-6.83M
2023Q4
2879
214.42M
91.26%
-6.60M
2023Q3
2767
215.95M
91.62%
-5.63M
2023Q2
2750
218.40M
92.12%
-4.32M
2023Q1
2729
219.91M
92.66%
-8.42M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
22.89M
10.13%
+843.35K
+3.83%
Apr 30, 2025
BlackRock Institutional Trust Company, N.A.
11.80M
5.22%
+21.89K
+0.19%
Mar 31, 2025
State Street Global Advisors (US)
10.65M
4.71%
-34.59K
-0.32%
Mar 31, 2025
T. Rowe Price Associates, Inc.
8.76M
3.88%
-1.48M
-14.44%
Mar 31, 2025
Wellington Management Company, LLP
5.79M
2.56%
-560.74K
-8.82%
Mar 31, 2025
Capital International Investors
5.56M
2.46%
+1.68M
+43.17%
Mar 31, 2025
Geode Capital Management, L.L.C.
5.17M
2.29%
+202.72K
+4.08%
Mar 31, 2025
Sanders Capital, LLC
4.67M
2.07%
-13.39K
-0.29%
Mar 31, 2025
Artisan Partners Limited Partnership
3.35M
1.48%
+474.93K
+16.51%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: hace 2 horas
Actualizado: hace 2 horas
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
10.66%
Brookstone Value Stock ETF
3.32%
GMO US Quality ETF
3.18%
Monarch Dividend Plus Index ETF
2.9%
NYLI Healthy Hearts ETF
2.86%
Madison Dividend Value ETF
2.41%
VictoryShares Free Cash Flow ETF
2.08%
Invesco S&P 500 Enhanced Value ETF
2.06%
First Eagle Global Equity ETF
2.02%
MarketDesk Focused US Dividend ETF
2.01%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción10.66%
Brookstone Value Stock ETF
Proporción3.32%
GMO US Quality ETF
Proporción3.18%
Monarch Dividend Plus Index ETF
Proporción2.9%
NYLI Healthy Hearts ETF
Proporción2.86%
Madison Dividend Value ETF
Proporción2.41%
VictoryShares Free Cash Flow ETF
Proporción2.08%
Invesco S&P 500 Enhanced Value ETF
Proporción2.06%
First Eagle Global Equity ETF
Proporción2.02%
MarketDesk Focused US Dividend ETF
Proporción2.01%
Dividendos
Un total de
6.19B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Apr 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 23, 2023
Jun 08, 2023
Jan 25, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 24, 2023
Mar 09, 2023
Oct 19, 2022
ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022
Dec 05, 2022
Dec 21, 2022
Dec 02, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
